Tyra Biosciences, Inc.

NasdaqGS:TYRA Stock Report

Market Cap: US$576.6m

Tyra Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TYRA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Feb 25SellUS$74,324Canaan Management, Inc.Company5,401US$13.76
23 Jan 25SellUS$78,466Canaan Management, Inc.Company4,825US$16.26
21 Jan 25SellUS$409,645Canaan Management, Inc.Company25,041US$16.40
25 Nov 24SellUS$88,773Canaan Management, Inc.Company5,272US$16.84
08 Nov 24BuyUS$19,836,066RA Capital Management, L.P.Company1,220,681US$16.25
08 Nov 24SellUS$31,696,800Boxer Capital Management, LLCCompany1,905,000US$20.55
07 Nov 24SellUS$1,284,133Canaan Management, Inc.Company74,582US$17.32
06 Nov 24SellUS$19,836,066Boxer Capital Management, LLCCompany1,220,681US$16.25
05 Nov 24SellUS$194,248Canaan Management, Inc.Company11,569US$17.01
01 Nov 24SellUS$2,282,656Canaan Management, Inc.Company138,711US$17.16
31 Oct 24SellUS$780,880MVA Associates, LLCCompany42,000US$20.63
30 Oct 24BuyUS$151,954Alan FuhrmanIndividual9,500US$16.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TYRA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies43,9390.0828%
General Public1,264,7702.38%
Individual Insiders2,210,3774.16%
Hedge Funds3,944,1947.43%
Institutions19,810,53737.3%
VC/PE Firms25,816,14048.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 91.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20%
RA Capital Management, L.P.
10,637,290US$115.5m0%1.62%
7.81%
Canaan Management, Inc.
4,144,590US$45.0m-0.84%36.25%
7.69%
Alta Partners LP
4,080,296US$44.3m0%91.94%
7.64%
Nextech Invest Ltd.
4,055,861US$44.0m0%9.02%
7.43%
BVF Partners L.P.
3,944,194US$42.8m-15.4%1.65%
5.85%
FMR LLC
3,107,951US$33.8m-7.85%no data
5.46%
TCG Crossover Management, LLC
2,898,103US$31.5m45.7%3.64%
3.82%
Boxer Capital Management, LLC
2,027,678US$22.0m0%2.08%
3.29%
Janus Henderson Group plc
1,746,320US$19.0m63.6%0.01%
3.19%
BlackRock, Inc.
1,695,917US$18.4m-1.31%no data
2.77%
OrbiMed Advisors LLC
1,470,086US$16.0m91.3%0.25%
2.56%
Todd Harris
1,357,168US$14.7m0.09%no data
2.27%
The Vanguard Group, Inc.
1,207,765US$13.1m-3.02%no data
1.89%
Farallon Capital Management, L.L.C.
1,000,981US$10.9m0%0.05%
1.86%
Vestal Point Capital, LP
990,000US$10.8m0%0.68%
1.77%
5AM Venture Management, LLC
939,298US$10.2m0%3.46%
1%
Kynam Capital Management, LP
530,478US$5.8m13.4%0.46%
0.97%
Geode Capital Management, LLC
517,578US$5.6m-1.07%no data
0.81%
Daniel Bensen
427,981US$4.6m0%no data
0.77%
State Street Global Advisors, Inc.
407,573US$4.4m5.94%no data
0.67%
Pictet Asset Management Limited
354,012US$3.8m0%no data
0.59%
Millennium Management LLC
315,141US$3.4m2,900%no data
0.46%
Jacobs Levy Equity Management Inc
244,245US$2.7m0%0.01%
0.45%
Sio Capital Management, LLC
240,870US$2.6m-39.9%0.87%
0.42%
Northern Trust Global Investments
222,764US$2.4m3.92%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 05:26
End of Day Share Price 2025/05/05 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tyra Biosciences, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason ZemanskyBofA Global Research
Mitchell KapoorH.C. Wainwright & Co.
Maurice RaycroftJefferies LLC